Home › Funds › TRANSCEND CAPITAL ADVISORS, LLC › JNJ

TRANSCEND CAPITAL ADVISORS, LLC position in JNJ

JOHNSON JOHNSON · Health Care

TRANSCEND CAPITAL ADVISORS, LLC reported holding 43,125 shares of JNJ (JOHNSON JOHNSON) in its Q2 2026 13F filing — a position valued at US$11.0M, representing 0.75% of its reported portfolio and ranking #23 among its reported holdings. TRANSCEND CAPITAL ADVISORS, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)43.12K sh
Reported value held$10.95M
Portfolio Weight0.75%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TRANSCEND CAPITAL ADVISORS, LLC's JNJ position evolved

TRANSCEND CAPITAL ADVISORS, LLC first disclosed a stake in JNJ in Q3 2023 at 112,636 shares (US$17.5M). Across 12 filings, TRANSCEND CAPITAL ADVISORS, LLC increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 43,125 shares valued at US$11.0M — an increase of 2,078 shares quarter over quarter.. Notable position changes include a 29% trim in Q2 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 112.64K $17.54M New
Q4 2023 103.82K $16.27M Reduce
Q1 2024 103.14K $16.32M Reduce
Q2 2024 73.19K $10.70M Reduce
Q3 2024 64.10K $10.39M Reduce
Q4 2024 57.24K $8.28M Reduce
Q1 2025 59.66K $9.89M Add
Q2 2025 58.86K $8.99M Reduce
Q3 2025 55.38K $10.27M Reduce
Q4 2025 43.92K $9.09M Reduce
Q1 2026 41.05K $10.03M Reduce
Q2 2026 43.12K $10.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has TRANSCEND CAPITAL ADVISORS, LLC held JNJ?

TRANSCEND CAPITAL ADVISORS, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TRANSCEND CAPITAL ADVISORS, LLC's current position in JNJ?

As of Q2 2026, TRANSCEND CAPITAL ADVISORS, LLC holds 43.12K shares of JNJ (JOHNSON JOHNSON), valued at $10.95M, representing 0.75% of its reported portfolio and ranking #23.

Has TRANSCEND CAPITAL ADVISORS, LLC been buying or selling JNJ?

In the latest 13F filing (Q2 2026), TRANSCEND CAPITAL ADVISORS, LLC increased its position in JNJ.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.